Lethal catatonia: The use of antipsychotics in the treatment. A case study;Letale katatonie: De plaats van antipsychotica in de behandeling

Tijdschrift voor Psychiatrie

Volumn 45, Issue 10, 2003, Pages 635-640

  Van Den Eede, F ^a,b   Van Hecke, J ^a   Van Den Bossche, B ^c   Sabbe, B G C ^a  

^a PC Sint Norbertushuis   (Belgium)

^b Afdeling Fase C   (Belgium)

^c NONE

Author keywords

Antipsychotics; Lethal catatonia; Neuroleptic malignant syndrome

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CLOZAPINE; DANTROLENE; DEXTROMETHORPHAN; DYDROGESTERONE PLUS ESTRADIOL; FLURAZEPAM; LORAZEPAM; NEUROLEPTIC AGENT; NORFLOXACIN; OLANZAPINE; PARACETAMOL; RISPERIDONE; SPASMOLYTIC AGENT;

ADULT; ARTICLE; CASE REPORT; CATATONIA; CLINICAL MEDICINE; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MEDICAL LITERATURE; MENTAL INSTABILITY; NEUROLEPTIC MALIGNANT SYNDROME; PSYCHOSIS; SYMPTOM;

EID: 0142184262     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4de versie). Washington, DC: American Psychiatric Press.
2. Bush, G., Fink, M., Petrides, G., e.a. (1996). Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatrica Scandinavica, 93, 237-243.
3. Caroff, S.N., Mann, S.C., Campbell, E.C., e.a. (2002). Movement disorders associated with atypical antipsychotic drugs. Journal of Clinical Psychiatry. 63(Suppl. 4),12-19.
4. Cassidy, E.M., O'Brien, M., Osman, M.F., e.a. (2002). Lethal catatonia responding to high-dose olanzapine therapy. Journal of Psychopharmacology, 15, 302-304.
5. Castillo, E., Rubin, R.T., & Holsboer-Trachsler, E. (1989). Clinical diffetentiation between lethal catatonia and neuroleptic malignant syndrome. American Journal of Psychiatry, 146, 324-328.
6. Filice, G.A., McDougall, B.C., Etcan Fang, N., e.a. (1998). Neuroleptic malignant syndrome associated with olanzapine. Annals of Pharmacotherapy, 32, 1158-1159.
7. Fink, M. (1996). Neuroleptic malignant syndrome and catatonia: one entity of two? Biological Psychiatry, 39, 1-4.
8. Fink, M. (2002). Catatonia and E C T: Meduna's biological antagonism hypothesis teconsideted. World Journal of Biological Psychiatry, 3, 205-208.
9. Lee, J.W., & Robertson S. (1997). Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report Annals of Clinical Psychiatry, 9, 165-169.
10. Levenson, J.L. (1985). Neuroleptic malignant syndrome. American Journal of Psychiatry, 142, 1137-1145.
11. Mann, S.C., Caroff, S.N., Bleier, H.R., e.a. (1986). Lethal catatonia. American Journal of Psychiatry, 143, 1374-1381.
12. Valevski, A., Loebl, T., Keren, T., e.a. (2001). Response of catatonia to risperidone: two case reports. Clinical Neuropharmacology, 24, 228-231.